Tumor reduction surgery and long-term survival in advanced ovarian cancer: A DACOVA study

Gynecologic Oncology

Volumn 38, Issue 2, 1990, Pages 203-209

  Bertelsen, Kamma ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ARTICLE; COMBINATION CHEMOTHERAPY; FEMALE; HISTOLOGY; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; OVARY CARCINOMA; PRIORITY JOURNAL; SURVIVAL; TUMOR GROWTH;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADENOCARCINOMA, SCIRRHOUS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CISPLATIN; COMBINED MODALITY THERAPY; COMPARATIVE STUDY; CYCLOPHOSPHAMIDE; DENMARK; DOXORUBICIN; ENDOMETRIOSIS; FEMALE; HUMAN; MIDDLE AGE; MULTICENTER STUDIES; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PHOSPHORAMIDE MUSTARDS; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE;

EID: 0025032521     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/0090-8258(90)90042-J     Document Type: Article

References (16)

1. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma
2. Diagnosis and staging of ovarian carcinoma
3. Randomised trial comparing two combination chemotherapy regimens (HEXA-CAF vs CHAP-5) in advanced ovarian carcinoma
4. The role of cytoreductive surgery in the treatment of patients with advanced ovarian carcinoma
5. A randomized study of cyclophosphamide and cisplatinum with or without doxorubicin in advanced ovarian carcinoma
6. Gruppo Interregionale Cooperativo Oncologico Ginecologia Randomised comparison of cisplatin with cyclophosphamide/cisplatin and with cyclophosphamide/doxorubicin/cisplatin in advanced ovarian cancer
7. Cytoreductive surgery in ovarian carcinoma: Feasibility and morbidity
8. The potential for optimal (⩽ 2 cm) cytoreductive surgery in advanced ovarian carcinoma at a tertiary medical center. A prospective study
9. The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma
10. Melphalan with and without doxorubicin in advanced ovarian cancer
11. Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma
12. Long-term survival after chemotherapy for advanced epithelial ovarian carcinoma
13. long-term results of two randomized studies of The Netherlands Joint Study Group for Ovarian Cancer
14. Second-look laparotomy in ovarian cancer: Evaluation of pathologic variables
15. Carcinoma of the ovary stage I and II. A prospective randomized study of the effects of postoperative chemotherapy and radiotherapy
16. The treatment of advanced ovarian carcinoma (II): Interval reassessment operations during chemotherapy